Abstract:ABSTRACT Background Electronic health records (EHRs) promise to enable broad-ranging discovery with power exceeding that of conventional research cohort studies. However, research using EHR datasets may be subject to selection bias, which can be compounded by missing data, limiting the generalizability of derived insights. Methods Mass General Brigham (MGB) is a large New England-based healthcare network comprising seven tertiary care and community hospitals with associated outpatient practices. Within an MGB-based EHR warehouse of >3.5 million individuals with at least one ambulatory care visit, we approximated a community-based cohort study by selectively sampling individuals longitudinally attending primary care practices between 2001-2018 (n=520,868), which we named the Community Care Cohort Project (C3PO). We also utilized pre-trained deep natural language processing (NLP) models to recover vital signs (i.e., height, weight, and blood pressure) from unstructured notes in the EHR. We assessed the validity of C3PO by deploying established risk models including the Pooled Cohort Equations (PCE) and the Cohorts for Aging and Genomic Epidemiology Atrial Fibrillation (CHARGE-AF) score, and compared model performance in C3PO to that observed within typical EHR Convenience Samples which included all individuals from the same parent EHR with sufficient data to calculate each score but without a requirement for longitudinal primary care. All analyses were facilitated by the JEDI Extractive Data Infrastructure pipeline which we designed to efficiently aggregate EHR data within a unified framework conducive to regular updates. Results C3PO includes 520,868 individuals (mean age 48 years, 61% women, median follow-up 7.2 years, median primary care visits per individual 13). Estimated using reports, C3PO contains over 2.9 million electrocardiograms, 450,000 echocardiograms, 12,000 cardiac magnetic resonance images, and 75 million narrative notes. Using tabular data alone, 286,009 individuals (54.9%) had all vital signs available at baseline, which increased to 358,411 (68.8%) after NLP recovery (31% reduction in missingness). Among individuals with both NLP and tabular data available, NLP-extracted and tabular vital signs obtained on the same day were highly correlated (e.g., Pearson r range 0.95-0.99, p<0.01 for all). Both the PCE models (c-index range 0.724-0.770) and CHARGE-AF (c-index 0.782, 95% 0.777-0.787) demonstrated good discrimination. As compared to the Convenience Samples, AF and MI/stroke incidence rates in C3PO were lower and calibration error was smaller for both PCE (integrated calibration index range 0.012-0.030 vs. 0.028-0.046) and CHARGE-AF (0.028 vs. 0.036). Conclusions Intentional sampling of individuals receiving regular ambulatory care and use of NLP to recover missing data have the potential to reduce bias in EHR research and maximize generalizability of insights.

Leveraging genomic diversity for discovery in an electronic health record linked biobank: the UCLA ATLAS Community Health Initiative

An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines

Implications of self-identified race, ethnicity, and genetic ancestry on genetic association studies in biobanks within health systems

Building a vertically integrated genomic learning health system: The biobank at the Colorado Center for Personalized Medicine

Genetic analyses of diverse populations improves discovery for complex traits

Abstract B012: Prioritization of ancestry-specific variations in disease data helps to alleviate bias in genomic data

Abstract C102: Polyethnic-1000: Advancing cancer genomics by studying ethnically diverse, underserved patient populations in New York

A framework for employing longitudinally collected multicenter electronic health records to stratify heterogeneous patient populations on disease history

Genetic landscape of colorectal cancer (CRC) across genetic ancestries: Implications for early cancer detection (ECD).

A framework for sharing of clinical and genetic data for precision medicine applications

Pan-UK Biobank GWAS improves discovery, analysis of genetic architecture, and resolution into ancestry-enriched effects

Instrumenting the health care enterprise for discovery research in the genomic era

Global Biobank Meta-analysis Initiative: Powering genetic discovery across human disease

Bayesian analysis of genetic association across tree-structured routine healthcare data in the UK Biobank

Cohort Design and Natural Language Processing to Reduce Bias in Electronic Health Records Research: The Community Care Cohort Project

Rare coding variant analysis for human diseases across biobanks and ancestries

Profiling and leveraging relatedness in a precision medicine cohort of 92,455 exomes

Genomic data in the All of Us Research Program

Biobank-scale characterization of Alzheimer's disease and related dementias identifies potential disease-causing variants, risk factors, and genetic modifiers across diverse ancestries

Analyses of biomarker traits in diverse UK biobank participants identify associations missed by European-centric analysis strategies

Harmonising and linking biomedical and clinical data across disparate data archives to enable integrative cross-biobank research